| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture.
|
Am J Physiol Cell Physiol
|
2005
|
1.91
|
|
2
|
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
|
J Neurooncol
|
2005
|
1.15
|
|
3
|
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease.
|
J Biol Chem
|
2001
|
1.10
|
|
4
|
Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system.
|
Eur J Histochem
|
2005
|
1.10
|
|
5
|
Acute variation of biochemical markers of muscle damage following a 21-km, half-marathon run.
|
Scand J Clin Lab Invest
|
2008
|
0.92
|
|
6
|
Immunocompetence of human microvascular brain endothelial cells: cytokine regulation of IL-1beta, MCP-1, IL-10, sICAM-1 and sVCAM-1.
|
J Neurol
|
1998
|
0.90
|
|
7
|
CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients.
|
J Neurooncol
|
2005
|
0.89
|
|
8
|
Detection of CSF 14-3-3 protein in Guillain-Barré syndrome.
|
Neurology
|
2006
|
0.84
|
|
9
|
Human brain endothelial cells and astrocytes produce IL-1 beta but not IL-10.
|
Scand J Immunol
|
1996
|
0.84
|
|
10
|
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients.
|
Neurology
|
2005
|
0.82
|
|
11
|
Cerebrospinal fluid interleukin-10 levels in primary central nervous system lymphoma: a possible marker of response to treatment?
|
Ann Neurol
|
2000
|
0.80
|
|
12
|
Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization.
|
Cancer Immunol Immunother
|
2004
|
0.79
|
|
13
|
In vitro modulation of adhesion molecules, adhesion phenomena, and fluid phase endocytosis on human umbilical vein endothelial cells and brain-derived microvascular endothelium by IFN-beta 1a.
|
J Interferon Cytokine Res
|
2001
|
0.78
|
|
14
|
Effects of beta-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study.
|
J Neuroimmunol
|
1997
|
0.77
|
|
15
|
Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients.
|
J Neuroimmunol
|
1998
|
0.77
|
|
16
|
Modulation of ICAM-1, VCAM-1 and HLA-DR by cytokines and steroids on HUVECs and human brain endothelial cells.
|
J Neurol Sci
|
1998
|
0.77
|
|
17
|
Modulation of experimental allergic encephalomyelitis in Lewis rats by administration of a peptide of Fas ligand.
|
J Autoimmun
|
2001
|
0.76
|
|
18
|
Oxidatively modified HDLs are potent inhibitors of cholesterol biosynthesis in human skin fibroblasts.
|
Arterioscler Thromb
|
1992
|
0.76
|
|
19
|
Right or wrong sample received for coagulation testing? Tentative algorithms for detection of an incorrect type of sample.
|
Int J Lab Hematol
|
2009
|
0.76
|
|
20
|
Pravastatin in vivo reduces mononuclear cell migration through endothelial monolayers.
|
Neurol Sci
|
2006
|
0.76
|
|
21
|
Acute variation of estimated glomerular filtration rate following a half-marathon run.
|
Int J Sports Med
|
2008
|
0.75
|
|
22
|
In vitro glatiramer acetate treatment of brain endothelium does not reduce adhesion phenomena.
|
Ann Neurol
|
2000
|
0.75
|
|
23
|
Long-term immunological changes in azathioprine-treated MS patients.
|
Neurol Sci
|
2000
|
0.75
|
|
24
|
Reduction of transendothelial migration of mononuclear cells in interferon-beta1b-treated multiple sclerosis patients.
|
Ann Neurol
|
1999
|
0.75
|